298 related articles for article (PubMed ID: 10222145)
1. Transformation-defective polyoma middle T antigen mutants defective in PLCgamma, PI-3, or src kinase activation enhance ERK2 activation and promote retinoic acid-induced, cell differentiation like wild-type middle T.
Yen A; Cherington V; Schaffhausen B; Marks K; Varvayanis S
Exp Cell Res; 1999 May; 248(2):538-51. PubMed ID: 10222145
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid selectively activates the ERK2 but not JNK/SAPK or p38 MAP kinases when inducing myeloid differentiation.
Yen A; Roberson MS; Varvayanis S
In Vitro Cell Dev Biol Anim; 1999 Oct; 35(9):527-32. PubMed ID: 10548434
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid increases amount of phosphorylated RAF; ectopic expression of cFMS reveals that retinoic acid-induced differentiation is more strongly dependent on ERK2 signaling than induced GO arrest is.
Yen A; Varvayanis S
In Vitro Cell Dev Biol Anim; 2000 Apr; 36(4):249-55. PubMed ID: 10852350
[TBL] [Abstract][Full Text] [Related]
4. Polyomavirus small t antigen prevents retinoic acid-induced retinoblastoma protein hypophosphorylation and redirects retinoic acid-induced G0 arrest and differentiation to apoptosis.
Yen A; Placanica L; Bloom S; Varvayanis S
J Virol; 2001 Jun; 75(11):5302-14. PubMed ID: 11333911
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest.
Yen A; Roberson MS; Varvayanis S; Lee AT
Cancer Res; 1998 Jul; 58(14):3163-72. PubMed ID: 9679985
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid-induced growth arrest and differentiation: retinoic acid up-regulates CD32 (Fc gammaRII) expression, the ectopic expression of which retards the cell cycle.
Wightman J; Roberson MS; Lamkin TJ; Varvayanis S; Yen A
Mol Cancer Ther; 2002 May; 1(7):493-506. PubMed ID: 12479267
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid-induced blr1 expression requires RARalpha, RXR, and MAPK activation and uses ERK2 but not JNK/SAPK to accelerate cell differentiation.
Battle TE; Roberson MS; Zhang T; Varvayanis S; Yen A
Eur J Cell Biol; 2001 Jan; 80(1):59-67. PubMed ID: 11211936
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid induces expression of SLP-76: expression with c-FMS enhances ERK activation and retinoic acid-induced differentiation/G0 arrest of HL-60 cells.
Yen A; Varvayanis S; Smith JL; Lamkin TJ
Eur J Cell Biol; 2006 Feb; 85(2):117-32. PubMed ID: 16439309
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid causes MEK-dependent RAF phosphorylation through RARalpha plus RXR activation in HL-60 cells.
Hong HY; Varvayanis S; Yen A
Differentiation; 2001 Aug; 68(1):55-66. PubMed ID: 11683493
[TBL] [Abstract][Full Text] [Related]
10. Increasing c-FMS (CSF-1 receptor) expression decreases retinoic acid concentration needed to cause cell differentiation and retinoblastoma protein hypophosphorylation.
Yen A; Sturgill R; Varvayanis S
Cancer Res; 1997 May; 57(10):2020-8. PubMed ID: 9158000
[TBL] [Abstract][Full Text] [Related]
11. retinoic acid, bromodeoxyuridine, and the Delta 205 mutant polyoma virus middle T antigen regulate expression levels of a common ensemble of proteins associated with early stages of inducing HL-60 leukemic cell differentiation.
Yen A; Lin DM; Lamkin TJ; Varvayanis S
In Vitro Cell Dev Biol Anim; 2004; 40(7):216-41. PubMed ID: 15638704
[TBL] [Abstract][Full Text] [Related]
12. Expression of activated RAF accelerates cell differentiation and RB protein down-regulation but not hypophosphorylation.
Yen A; Williams M; Platko JD; Der C; Hisaka M
Eur J Cell Biol; 1994 Oct; 65(1):103-13. PubMed ID: 7889981
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid, bromodeoxyuridine, and the Δ205 mutant polyoma virus middle T antigen regulate expression levels of a common ensemble of proteins associated with early stages of inducing HL-60 leukemic cell differentiation.
Yen A; Lin DM; Lamikin TJ; Varvayanis S
In Vitro Cell Dev Biol Anim; 2004 Jul; 40(7):216-41. PubMed ID: 27520281
[TBL] [Abstract][Full Text] [Related]
14. Nongenomic vitamin D3 analogs activating ERK2 in HL-60 cells show that retinoic acid-induced differentiation and cell cycle arrest require early concurrent MAPK and RAR and RXR activation.
Yen A; Norman AW; Varvayanis S
In Vitro Cell Dev Biol Anim; 2001 Feb; 37(2):93-9. PubMed ID: 11332745
[No Abstract] [Full Text] [Related]
15. Roscovitine enhances All-trans retinoic acid (ATRA)-induced leukemia cell differentiation: Novel effects on signaling molecules for a putative Cdk2 inhibitor.
Rashid A; Duan X; Gao F; Yang M; Yen A
Cell Signal; 2020 Jul; 71():109555. PubMed ID: 32032659
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid-induced CD38 expression in HL-60 myeloblastic leukemia cells regulates cell differentiation or viability depending on expression levels.
Lamkin TJ; Chin V; Varvayanis S; Smith JL; Sramkoski RM; Jacobberger JW; Yen A
J Cell Biochem; 2006 Apr; 97(6):1328-38. PubMed ID: 16329108
[TBL] [Abstract][Full Text] [Related]
17. A retinoic acid receptor beta/gamma-selective prodrug (tazarotene) plus a retinoid X receptor ligand induces extracellular signal-regulated kinase activation, retinoblastoma hypophosphorylation, G0 arrest, and cell differentiation.
Yen A; Fenning R; Chandraratna R; Walker P; Varvayanis S
Mol Pharmacol; 2004 Dec; 66(6):1727-37. PubMed ID: 15383624
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid-induced blr1 expression promotes ERK2 activation and cell differentiation in HL-60 cells.
Battle TE; Levine RA; Yen A
Exp Cell Res; 2000 Feb; 254(2):287-98. PubMed ID: 10640427
[TBL] [Abstract][Full Text] [Related]
19. FMS (CSF-1 receptor) prolongs cell cycle and promotes retinoic acid-induced hypophosphorylation of retinoblastoma protein, G1 arrest, and cell differentiation.
Yen A; Sturgill R; Varvayanis S; Chern R
Exp Cell Res; 1996 Nov; 229(1):111-25. PubMed ID: 8940255
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid-induced RB (retinoblastoma) hypophosphorylation enhanced by CGP 52411 (4,5-dianilinophthalimide), an EGF family tyrosine kinase receptor inhibitor.
Yen A; Soong S
Eur J Cell Biol; 1996 Apr; 69(4):327-34. PubMed ID: 8741214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
